156 related articles for article (PubMed ID: 8288039)
1. The aldose reductase controversy.
Frank RN
Diabetes; 1994 Feb; 43(2):169-72. PubMed ID: 8288039
[No Abstract] [Full Text] [Related]
2. The identification of aldose reductase in the pathogenesis of diabetic complications: the background.
Kador PF; Kinoshita JH
Diabet Med; 1985 May; 2(3):187-9. PubMed ID: 2952417
[No Abstract] [Full Text] [Related]
3. Aldose reductase inhibitors and the complications of diabetes mellitus.
Tomlinson DR
Diabet Med; 1993 Apr; 10(3):214-30. PubMed ID: 8485953
[No Abstract] [Full Text] [Related]
4. Aldose reductase inhibitors.
Kirchain WR; Rendell MS
Pharmacotherapy; 1990; 10(5):326-36. PubMed ID: 2122421
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization for aldose reductase in diabetic lenses.
Akagi Y; Kador PF; Kinoshita JH
Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):163-7. PubMed ID: 3100473
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase inhibitors and diabetic complications.
Raskin P; Rosenstock J
Am J Med; 1987 Aug; 83(2):298-306. PubMed ID: 3113248
[No Abstract] [Full Text] [Related]
7. Aldose reductase inhibitors and their potential for the treatment of diabetic complications.
Tomlinson DR; Stevens EJ; Diemel LT
Trends Pharmacol Sci; 1994 Aug; 15(8):293-7. PubMed ID: 7940997
[TBL] [Abstract][Full Text] [Related]
8. Aldose reductase in the diabetic eye. XLIII Edward Jackson memorial lecture.
Kinoshita JH
Am J Ophthalmol; 1986 Dec; 102(6):685-92. PubMed ID: 3098107
[TBL] [Abstract][Full Text] [Related]
9. Polyol pathway in the pathogenesis of diabetic complications and aldose reductase inhibitors.
Madhu SV; Verma NP; Goel A; Kapoor VK
J Assoc Physicians India; 1992 Oct; 40(10):679-81. PubMed ID: 1307356
[No Abstract] [Full Text] [Related]
10. [Sorbitol, phosphoinositides and Na K-ATPase in the pathogenesis of diabetic complications].
Greene DA; Sima AA; Lattimer SA
Journ Annu Diabetol Hotel Dieu; 1988; ():105-17. PubMed ID: 2845181
[No Abstract] [Full Text] [Related]
11. Aldose reductase: black sheep or skeleton in the cupboard?
Crabbe MJ; Goode D; Wolff SP
Nat Struct Biol; 1996 Aug; 3(8):659-61. PubMed ID: 8756319
[No Abstract] [Full Text] [Related]
12. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
Shindo H; Tawata M; Aida K; Onaya T
J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
[TBL] [Abstract][Full Text] [Related]
13. Aldose reductase in diabetic cataracts.
Kinoshita JH; Kador P; Catiles M
JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
[No Abstract] [Full Text] [Related]
14. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
[TBL] [Abstract][Full Text] [Related]
15. Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage.
Greene DA; Sima AA; Stevens MJ; Feldman EL; Killen PD; Henry DN; Thomas T; Dananberg J; Lattimer SA
Diabetes Metab Rev; 1993 Oct; 9(3):189-217. PubMed ID: 8187607
[No Abstract] [Full Text] [Related]
16. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
Hotta N; Sakamoto N
Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
[No Abstract] [Full Text] [Related]
17. Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications.
Giannoukakis N
Expert Opin Investig Drugs; 2008 Apr; 17(4):575-81. PubMed ID: 18363521
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductase in the etiology of diabetic complications: I. Introduction.
Harrison HE; Stribling D; Armstrong FM; Perkins CM
J Diabet Complications; 1989; 3(1):6-11. PubMed ID: 2540215
[No Abstract] [Full Text] [Related]
19. [Diabetes mellitus and its complications in Japan. Polyol pathway and diabetic neuropathy: selective preventive effect of aldose reductase inhibitor on the experimental diabetic neuropathy].
Kamijo M; Yagihashi S
Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1457-9. PubMed ID: 1837043
[No Abstract] [Full Text] [Related]
20. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
